W. de Bruijn Et Al. , "Introduction and utilization of high priced HCV medicines across Europe; implications for the future," Frontiers in Pharmacology , vol.7, no.JUL, 2016
de Bruijn, W. Et Al. 2016. Introduction and utilization of high priced HCV medicines across Europe; implications for the future. Frontiers in Pharmacology , vol.7, no.JUL .
de Bruijn, W., Ibáñez, C., Frisk, P., Bak Pedersen, H., Alkan, A., Vella Bonanno, P., ... Brkicic, L. S.(2016). Introduction and utilization of high priced HCV medicines across Europe; implications for the future. Frontiers in Pharmacology , vol.7, no.JUL.
de Bruijn, Winnie Et Al. "Introduction and utilization of high priced HCV medicines across Europe; implications for the future," Frontiers in Pharmacology , vol.7, no.JUL, 2016
de Bruijn, Winnie d. Et Al. "Introduction and utilization of high priced HCV medicines across Europe; implications for the future." Frontiers in Pharmacology , vol.7, no.JUL, 2016
de Bruijn, W. Et Al. (2016) . "Introduction and utilization of high priced HCV medicines across Europe; implications for the future." Frontiers in Pharmacology , vol.7, no.JUL.
@article{article, author={Winnie de Bruijn Et Al. }, title={Introduction and utilization of high priced HCV medicines across Europe; implications for the future}, journal={Frontiers in Pharmacology}, year=2016}